PULMONER EMBOLİ HASTALARININ YOĞUN BAKIM TAKİBİ

Amaç: Pulmoner emboli yakın takip ve acil müdahale gerektiren ölümcül bir hastalıktır. Amacımız bu hastaların yoğun bakımımızdaki süreçlerini incelemektir.

Anahtar Kelimeler:

Yoğun bakım, pulmoner emboli, mortalite

Monitoring of Pulmonary Emboli Patients in Intensive Care Unit

Objective: Pulmonary embolism is a fatal disease that requires close follow-up and urgent intervention. Our aim is to examine the processes of these patients in our intensive care.

Keywords:

Intensive care, pulmonary embolism, mortality,

PDF

___

1. Alikhan R, Peters F, Wilmott R, Cohen AT. Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol. 2004;57(12):1254-7.
2. Heit JA, O’Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162(11):1245-8.
3. Palevsky HL, Kelly MA, Fishman AP. Pulmonary thromboembolic disease. In: Fishman AP, ed. Fishman’s Pulmonary Diseases and Disorders. 3rd ed. New York. Mc Graw-Hill, 1998;1297-329.
4. Wagenvoort CA. Pathology of pulmonary thromboembolism. Chest. 1995;107(1):10-7.
5. Saygıner A. Akciğer embolizmi. In: İliçin G, Ünal S, Biberoğlu K, Akalın S, Süleymanlar G, eds. Temel İç Hastalıkları. Ankara. Güneş Tıp Kitabevi, 1996;538-43.
6. Morgenthaler TI, Ryu JH. Clinical characteristics of fatal pulmonary embolism in a referral hospital. Mayo Clin Proc. 1995;70(5):417-24.
7. Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res. 2016;118(9):1340-47.
8. Harold I, Mark A. Pulmonary thromboembolic disease. In: Fishman AP, ed. Pulmonary Disease and Disorders. Newyork. Mc Graw-Hill Book Company, 1998;1297-329.
9. Guintini C, Di Rocco G, Marini C, Melillo E, Palla A. Pulmonary embolism: Epidemiology. Chest. 1995;107:3-9.
10. Manganelli D, Polla A, Donnamaria V. Clinical features of pulmonary embolism. Chest. 1995;107(1):25-32.
11. Sakuma M, Nakamura M, Nakanishi N, Miyahara Y, Tanabe N, Yamada N et al. Inferior vena cava filter is a new additional therapeutic option to reduce mortality from acute pulmonary embolism. Circ J. 2004;68(9):816-18.
12. The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Accessed date: 17.08.2021: www.ncbi.nlm.nih.gov/books/NBK44178/.
13. Silverstein MD, Heit JA, Moher DN, Petterson TM, O'Fallon WM, Melton LJ et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population based study. Arch Intern Med. 1998;158(6):585-93.
14. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galie N, Pruszczyk P et al. Guidelines on the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008;29(18):2276-315.
15. Golbaşı Z. Chronic thromboembolic pulmonary hypertension: diagnosis, medical therapy and monitoring. Anadolu Kardiyol Derg. 2010;10(2):56-60.
16. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N et al. ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033-69.
17. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353(9162):1386-89.
18. Kabrhel C, Mark Courtney D, Camargo CA, Moore CL, Richman PB, Plewa MC et al. Potential impact of adjusting the threshold of the quantitative D-dimer based on pretest probability of acute pulmonary embolism. Acad Emerg Med. 2009;16(4):325-32.
19. Becattini C, Lignani A, Masotti L, Forte MB, Agnelli G. D-dimer for risk stratification in patients with acute pulmonary embolism. J Thromb Thrombolysis. 2012;33(1):48-57.
20. Kollef MH, Zahid M, Eisenberg PR. Predictive value of rapid semiquantative D-dimer assay in critically ill patients with suspected venous thromboembolic disease. Crit Care Med. 2000;28(2):414-20.
21. Kostrubiec M, Labyk A, Pedowska-Wloszek J, S Pacho, A Wojciechowski, K Jankowski et al. Assessment of renal dysfunction improves troponin-based shortterm prognosis in patients with acute symptomatic pulmonary embolism. J Thromb Haemost. 2010;8(4):654-58.
22. Ozbudak O, Erogullari I, Oğuz C, Cilli A, Turkay M, Ozdemir T. Doppler ultrasonography versus venography in the detection of deep vein thormbosis in patients with pulmonary embolism. J Thromb Trombolysis. 2006;21(2):159-62.
23. Van Belle A, Buller HR, Huisman MV, Huisman PM, Kaasjager K, Kamphuisen PW et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA. 2006;295(2):172-79.
24. Naidich DP, Zerhouni EA, Müller NL, Webb WR, Krinsky GA, Siegelman SS. Computed tomography and magnetic resonance of the thorax. 3rd ed. New York. Lippincott-Raven, 1999.
25. De Monye W, van Strijen MJ, Huisman MV, Kieft GJ, Pattynama PM. Suspected pulmonary embolism: Prevalence and anatomic distribution in 487 consecutive patients. Advances in new technologies evaluating the localisation of pulmonary embolism (ANTELOPE) group. Radiology. 2000;215(1):184-88.
26. Şen E, Arslan F, Eladağ Yurt S, Tarakcı N, Kaya A, Atasoy C ve ark. Pulmoner bilgisayarlı tomografi anjiyografi ile pulmoner tromboemboli tanısı konulan hastalarda klinik ve radyolojik bulgular. Tuberkuloz ve Toraks Dergisi. 2009;57(1):5-13.
27. Duru S, Ergün R, Dilli A, Kaplan T, Kaplan B, Ardıç S. Pulmoner embolide klinik, laboratuvar ve bilgisayarlı tomografi pulmoner anjiyografi sonuçları: 205 hastanın retrospektif değerlendirmesi. Anadolu Kardiyol Derg. 2012;12(1):142-9.
28. Messika J, Goutorbe P, Hajage D, Ricard JD. Severe pulmonary embolism managed with high-flow nasal cannula oxygen therapy. Eur J Emerg Med. 2017;24(3):230-32.
29. THESEE study group. A comparison of low-molecular weight heparin with unfractioned heparin for acute pulmonary embolism. N Engl J Med. 1997;337(10):663-69.
30. Uçar EY. Thrombolitic treatment. Türkiye Klinikleri J Pulm Med-Special Topics. 2016;9:39-43.
31. Hasanoglu HC, Hezer H, Karalezli A, Arguder E, Kilic H, Sentürk A et al. Half dose recombinant tissue plasminogen activatortreatment in venous thromboembolism. J Investig Med. 2014;62(1):71-77.
32. Sharifi M, Berger J, Beeston P, Bay C, Vajo Z, Javadpoor S. Pulseless electrical activity in pulmonary embolism treated with thrombolysis (From the “PEAPETT” Study). Am J Emerg Med. 2016;34(10):1963-67.
33. Truhlář A, Deakin CD, Soar J, Khalifa GE, Alfonzo A, Bierens JJ et al. European Resuscitation Council Guidelines for Resuscitation 2015: Section 4. Cardiac arrest in special circumstances. Resuscitation. 2015;95:148-201.
34. Alizoroğlu D, Erbaycu A E, Çimen P, Ediboğlu Ö, Kıraklı C. Kardiyopulmoner arrest gelişen masif pulmoner embolide trombolitik kullanımı: hayata dönen iki hasta. Turk J Intensive Care. 2019;17:102-6.
35. Vishal S, Mehta N, Rawat N, Lehrman SG, Aronow WS. Management of massive and nonmassive pulmonary embolism. Arch Med Sci. 2012;6:957-69.